Multicohort Study of Conditional Survival and Cause of Death After Achieving Event-Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)

被引：0
|
作者：
Wang, Yucai [1 ]
Larson, Melissa [1 ]
Ekberg, Sara [2 ]
Smedby, Karin [2 ]
Zhao, Eric [3 ]
Gerrie, Alina [3 ]
Farooq, Umar [4 ]
Maurer, Matthew [1 ]
Paludo, Jonas [1 ]
Nowakowski, Grzegorz [1 ]
Habermann, Thomas [1 ]
Albertsson-Lindblad, Alexandra [5 ]
Glimelius, Ingrid [6 ]
Link, Brian [4 ]
Villa, Diego [3 ]
Jerkeman, Mats [5 ]
Cerhan, James [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Karolinska Inst, Stockholm, Sweden
[3] BC Canc, Vancouver, BC, Canada
[4] Univ Iowa, Iowa City, IA USA
[5] Lund Univ, Lund, Sweden
[6] Uppsala Univ, Uppsala, Sweden
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
mantle cell lymphoma; event-free survival at 24 months (EFS24); overall survival; cause of death;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MCL-063
引用
收藏
页码：S457 / S458
页数：2
相关论文
共 50 条
  • [1] An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma
    Wang, Yucai
    Larson, Melissa C.
    Farooq, Umar
    Ekberg, Sara
    Smedby, Karin Ekstroem
    Simonsen, Mikkel Runason
    Niemann, Carsten Utoft
    Zhao, Eric J.
    Gerrie, Alina S.
    Switchenko, Jeffrey M.
    Bond, David A.
    Bachanova, Veronika
    Barta, Stefan K.
    Hill, Brian T.
    Martin, Peter
    Danilov, Alexey
    Grover, Natalie S.
    Karmali, Reem
    Ghosh, Nilanjan
    Fenske, Timothy S.
    Kahl, Brad S.
    Albertsson-Lindblad, Alexandra
    Glimelius, Ingrid Cecilia
    Al-Mashhadi, Ahmed Ludvigsen
    Larsen, Thomas Stauffer
    Maddocks, Kami J.
    Link, Brian K.
    Paludo, Jonas
    Nowakowski, Grzegorz S.
    Habermann, Thomas M.
    Maurer, Matthew J.
    Villa, Diego
    Cohen, Jonathon B.
    El-Galaly, Tarec Christoffer Christoffer
    Jerkeman, Mats
    Cerhan, James R.
    BLOOD, 2023, 142
  • [2] Prognostic Role of Event-free Survival at 24 Months (EFS24) in Newly Diagnosed Mantle Cell Lymphoma (MCL)
    Wang, Yucai
    Larson, Melissa C.
    Maurer, Matthew J.
    Link, Brian K.
    Farooq, Umar
    Witzig, Thomas E.
    Habermann, Thomas M.
    Cerhan, James R.
    Nowakowski, Grzegorz S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S394 - S394
  • [3] An International Assessment of Event-Free Survival at 24 Months (EFS24) and Subsequent Survival in Peripheral T-Cell Lymphoma
    Maurer, Matthew J.
    Ellin, Fredrik
    Srour, Line
    Jerkeman, Mats
    Bennani, Nabila Nora
    Connors, Joseph M.
    Smedby, Karin Ekstrom
    Ansell, Stephen
    Link, Brian K.
    Cerhan, James R.
    Relander, Thomas
    Savage, Kerry J.
    Feldman, Andrew L.
    BLOOD, 2016, 128 (22)
  • [4] Event-Free Survival at 24 Months (EFS24) Becomes an Important Clinical Endpoint in Newly Diagnosed Mantle Cell Lymphoma in the New Era
    Wang, Yucai
    Larson, Melissa C.
    Castellino, Alessia
    Maurer, Matthew J.
    Feldman, Andrew L.
    Syrbu, Sergei
    Link, Brian K.
    Farooq, Umar
    Inwards, David J.
    Paludo, Jonas
    Witzig, Thomas E.
    Habermann, Thomas M.
    Cerhan, James R.
    Nowakowski, Grzegorz S.
    BLOOD, 2021, 138
  • [5] IPI24: An International Study To Create IPI For The Event-Free Survival At 24 Months (EFS24)Endpoint For DLBCL In The Immunocheomotherapy Era
    Maurer, Matthew J.
    Ghesquieres, Herve
    Jais, Jean-Philippe
    Witzig, Thomas E.
    Haioun, Corinne
    Thompson, Carrie A.
    Delarue, Richard
    Micallef, Ivana N.
    Peyrade, Frederic
    Macon, William R.
    Molina, Thierry Jo
    Ketterer, Nicolas
    Syrbu, Sergei I.
    Fitoussi, Olivier
    Kurtin, Paul J.
    Allmer, Cristine
    Nicolas-Virelizier, Emmanuelle
    Slager, Susan L.
    Habermann, Thomas M.
    Link, Brian K.
    Salles, Gilles Andre
    Tilly, Herve
    Cerhan, James R.
    BLOOD, 2013, 122 (21)
  • [6] International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
    Maurer, Matthew J.
    Ellin, Fredrik
    Srour, Line
    Jerkeman, Mats
    Bennani, N. Nora
    Connors, Joseph M.
    Slack, Graham W.
    Smedby, Karin E.
    Ansell, Stephen M.
    Link, Brian K.
    Cerhan, James R.
    Relander, Thomas
    Savage, Kerry J.
    Feldman, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 4019 - +
  • [7] Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
    Kim, Yu Ri
    Kim, Soo-Jeong
    Lee, Hye Sun
    Jeon, Soyoung
    Cho, Hyunsoo
    Chung, Haerim
    Jang, Ji Eun
    Cheong, June-Won
    Min, Yoo Hong
    Kim, Jin Seok
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 613 - 620
  • [8] Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
    Maurer, Matthew J.
    Jais, Jean-Philippe
    Ghesquieres, Herve
    Witzig, Thomas E.
    Hong, Fangxin
    Haioun, Corinne
    Thompson, Carrie A.
    Thieblemont, Catherine
    Micallef, Ivana N.
    Porrata, Luis F.
    Ribrag, Vincent
    Nowakowski, Gregorz S.
    Casasnovas, Olivier
    Bologna, Serge
    Morschhauser, Franck
    Morrison, Vicki A.
    Peterson, Bruce A.
    Macon, William R.
    Copie-Bergman, Christiane
    Feldman, Andrew L.
    Syrbu, Sergei I.
    Kurtin, Paul J.
    Gascoyne, Randy D.
    Li, Hailun
    Allmer, Cristine
    Kahl, Brad S.
    Ansell, Stephen M.
    Slager, Susan L.
    Link, Brian K.
    Salles, Gilles
    Habermann, Thomas M.
    Tilly, Herve
    Cerhan, James R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (02) : 179 - 184
  • [9] Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study
    Abu Sabaa, Amal
    Morth, Charlott
    Hasselblom, Sverker
    Hedstrom, Gustaf
    Flogegard, Max
    Stern, Mimmi
    Andersson, Per-Ola
    Glimelius, Ingrid
    Enblad, Gunilla
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (05) : 906 - 914
  • [10] Relapses after Achieving EFS24 in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Wang, Yucai
    Farooq, Umar
    Link, Brian K.
    Hefazi, Mehrdad
    Allmer, Cristine
    Maurer, Matthew J.
    Witzig, Thomas E.
    Habermann, Thomas M.
    Ansell, Stephen M.
    Cerhan, James R.
    Nowakowski, Grzegorz S.
    BLOOD, 2018, 132
12345